Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
TNFA-L
i
Other names:
Tumor Necrosis Factor, Tumor Necrosis Factor Ligand Superfamily Member 2, Cachectin, TNF-Alpha, TNFSF2, TNF-A, TNFA, Tumor Necrosis Factor (TNF Superfamily, Member 2), Tumor Necrosis Factor Ligand 1F, Tumor Necrosis Factor-Alpha, TNF Superfamily, Member 2, TNF Macrophage-Derived, TNF Monocyte-Derived, APC1 Protein, TNLG1F
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
405785
Related biomarkers:
Expression
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
TNFA-L
Diffuse Large B Cell Lymphoma
TNFA-L
Diffuse Large B Cell Lymphoma
relmacabtagene autoleucel
Sensitive: C3 – Early Trials
relmacabtagene autoleucel
Sensitive
:
C3
relmacabtagene autoleucel
Sensitive: C3 – Early Trials
relmacabtagene autoleucel
Sensitive
:
C3
TNFA-L
Cholangiocarcinoma
TNFA-L
Cholangiocarcinoma
bexmarilimab
Sensitive: C3 – Early Trials
bexmarilimab
Sensitive
:
C3
bexmarilimab
Sensitive: C3 – Early Trials
bexmarilimab
Sensitive
:
C3
TNFA-L
Melanoma
TNFA-L
Melanoma
bexmarilimab
Sensitive: C3 – Early Trials
bexmarilimab
Sensitive
:
C3
bexmarilimab
Sensitive: C3 – Early Trials
bexmarilimab
Sensitive
:
C3
TNFA-L
Gastric Cancer
TNFA-L
Gastric Cancer
bexmarilimab
Sensitive: C3 – Early Trials
bexmarilimab
Sensitive
:
C3
bexmarilimab
Sensitive: C3 – Early Trials
bexmarilimab
Sensitive
:
C3
TNFA-L
Melanoma
TNFA-L
Melanoma
pucotenlimab
Sensitive: C3 – Early Trials
pucotenlimab
Sensitive
:
C3
pucotenlimab
Sensitive: C3 – Early Trials
pucotenlimab
Sensitive
:
C3
TNFA-L
Cutaneous T-cell Lymphoma
TNFA-L
Cutaneous T-cell Lymphoma
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
TNFA-L
Peripheral T-cell Lymphoma
TNFA-L
Peripheral T-cell Lymphoma
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login